Mosaiques provides highly innovative proteomics services using a unique CE-MS technology that profiles the polypeptides of body fluids. Measurement of the proteome in combination with database annotation is the key to an all-in-one diagnostic for a wide spectrum of clinical applications, including (but not limited to): early stage diagnosis of serious diseases, controlling efficiency of applied therapies, examining efficacy of new drugs, identifying new therapeutic targets, etc.

Kaposi sarcoma is a vascular tumor invariably associated with KSHV infection in all its clinical forms (post-transplant, classic, endemic, and AIDS-related). The incidence of the post-transplant form of KS varies in different ethnic groups from 0.5% to 5.3%. Sensitive tests for non-invasive diagnosis and identification of patients at high risk to develop KS are still lacking. Mosaiques diagnostics will profile spot urine samples of patients suffering from KS using its CE-MS technology and then employ these profiles for non-invasive identification of those patients at high risk to develop KS.

Decramer, S., Wittke, S., et al. (2006) Predicting the clinical outcome of congenital unilateral ureteropelvic junction obstruction in newborn by urinary proteome analysis. Nat.Med. 12, 398-400 Fliser, D., Novak, J., et al. (2007) Advances in urinary proteome analysis and biomarker discovery. J Am Soc Nephrol. 18, 1057-1071 Kaiser, T., Hermann, A., et al. (2003) Capillary electrophoresis coupled to mass spectrometry to establish polypeptide patterns in dialysis fluids. J Chromatogr.A 1013, 157-171 Mischak, H., Apweiler, R., et al. (2007) Clinical Proteomics: a need to define the field and to begin to set adequate standards. PROTEOMICS - Clinical Applications 1, 148-156 Schiffer, E., Mischak, H., and Novak, J. (2006) High resolution proteome/peptidome analysis of body fluids by capillary electrophoresis coupled with MS. Proteomics. 6, 5615-5627 Theodorescu, D., Wittke, S., et al. (2006) Discovery and validation of new protein biomarkers for urothelial cancer: a prospective analysis. Lancet Oncol 7, 230-240 Weissinger, E. M., Schiffer, E., et al. (2007) Proteomic patterns predict acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Blood 109, 5511-5519 Zurbig, P., Renfrow M.B., et al. (2006) Biomarker discovery by CE-MS enables sequence analysis via MS/MS with platform-independent separation. Electrophoresis 27, 2111-2125